Poseida Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Poseida Therapeutics, Inc. had Operating Lease, Liability, Noncurrent of $17.73 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2024-11-07
- 2024-09-30: Operating Lease, Liability, Noncurrent $17.73M.
- 2024-06-30: Operating Lease, Liability, Noncurrent $18.82M.
- 2024-03-31: Operating Lease, Liability, Noncurrent $19.88M.
- 2023-12-31: Operating Lease, Liability, Noncurrent $20.88M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2024-09-30 | $17.73M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $18.82M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $19.88M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $20.88M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $21.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $22.82M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $23.75M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $24.64M 10-K · filed 2024-03-07 |
| 2022-09-30 | $25.73M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $26.80M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $27.85M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $25.50M 10-K · filed 2023-03-09 |
| 2021-09-30 | $25.38M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $26.09M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $26.78M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $25.37M 10-K · filed 2022-03-10 |
| 2020-09-30 | $25.61M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $21.19M 10-Q · filed 2020-08-20 |